A systematic review of economic evaluations of pharmacological treatments for adults with chronic migraine.

ABSTRACT:

Background and aims

Chronic migraine is a common neurovascular brain disorder with substantial economic costs. We performed a systematic review to identify economic evaluations of pharmacological treatments for adults with chronic migraine.

Methods

We undertook systematic literature searches using terms for migraine/headache and prophylactic drug interventions, combined with economic/cost terms where appropriate. Using inclusion and exclusion criteria, two reviewers independently assessed the citations and abstracts, and full-text articles were retrieved. A review of study characteristics and methodological quality was assessed.

Results

Sixteen citations met the inclusion criteria and were model-based cost-utility studies evaluating: Botox (n = 6); Erenumab (n = 8); F

SUBMITTER: Khanal S 

PROVIDER: S-EPMC9479409 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature